Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by steadfaston Jun 02, 2022 4:55pm
207 Views
Post# 34727741

RE:RE:Hopefully on Monday, Dr Witkowski can update his Abstract

RE:RE:Hopefully on Monday, Dr Witkowski can update his AbstractThank you for your kind advice, BioTeck.  From my Career Days, if I were a Member of
SVA I.R. Team, I would consider to-day we are unequivocally failures,  for SVA to be
trading on the TSE the 1st day of Trading, the TSX up 318 pts, DJ+435 pts, Nas +322 pts
SVA down 3 cents on below average volume of 174,700 vs 3 mos av 195,939.  In my
days my A Team would have ensured to have a line up of buyers on 1st day. 
Where were the Inst'l Buyers that SVA have been talking about?  Obviously, my work
ethic was much superior and I expect others to perform to their very best ability.
I wonder how the Echelon Analyst feels today and the other analysts that have written
positive reports on SVA.  Somebody needs to be cracking the whip.

Bioteck, thank you for the DD you provide.


<< Previous
Bullboard Posts
Next >>